Lista de obras - Ramzi Ajjan - Dominio Público Uruguay

A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes ⬇️

artículo científico publicado en 2016

A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease

artículo científico publicado en 2013

A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control

artículo científico publicado en 2021

Antiplatelet Therapies in Diabetes

scientific article published on 06 March 2020

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis

artículo científico publicado en 2018

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

artículo científico

Cardiovascular magnetic resonance assessment of ventricular morphology to investigate the mechanisms of heart failure associated with type 2 diabetes

artículo científico publicado en 2015

Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes ⬇️

artículo científico publicado en 2018

Coagulation and atherothrombotic disease

artículo científico publicado en 2005

Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity

artículo científico publicado en 2007

Complement C3 and C-reactive protein levels in patients with stable coronary artery disease

artículo científico publicado en 2005

Complement C3 is a novel plasma clot component with anti-fibrinolytic properties

artículo científico publicado en 2012

Confusion over thiazolidinedione-induced heart failure: need for a better definition of heart failure

artículo científico publicado en 2008

Coronary artery disease-associated genetic variants and biomarkers of inflammation ⬇️

artículo científico publicado en 2017

Corrigendum: The Effect of a Simulated Commercial Flight Environment With Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants With Type 2 Diabetes - A Cross-Over Study.

artículo científico publicado en 2018

Development of a supported self-management intervention for adults with type 2 diabetes and a learning disability. ⬇️

artículo científico publicado en 2018

Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure ⬇️

artículo científico publicado en 2017

Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology

artículo científico publicado en 2013

Effects of MASP-1 of the Complement System on Activation of Coagulation Factors and Plasma Clot Formation ⬇️

artículo científico publicado el 20 de abril de 2012

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy ⬇️

artículo científico publicado en 2018

Fibrin clot structure and platelet aggregation in patients with aspirin treatment failure

artículo científico publicado en 2013

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial ⬇️

scientific article published on 20 December 2016

Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes

artículo científico publicado en 2013

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk ⬇️

artículo científico publicado en 2017

Hypoglycaemia, thrombosis and vascular events in diabetes

artículo científico publicado en 2016

Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study

artículo científico publicado en 2020

Inhibition of complement C3 and fibrinogen interaction: a potential novel therapeutic target to reduce cardiovascular disease in diabetes

artículo científico publicado en 2015

Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls

artículo científico publicado en 2014

Managing with Learning Disability and Diabetes: OK-Diabetes - a case-finding study and feasibility randomised controlled trial ⬇️

article by Allan House et al published May 2018 in Health Technology Assessment

Platelet count, platelet turnover and fibrin clot structure in patients with coronary artery disease

artículo científico publicado en 2014

Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes ⬇️

Raising awareness of Graves' orbitopathy with early warning cards

artículo científico publicado en 2017

Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke

artículo científico publicado en 2009

The Effect of a Simulated Commercial Flight Environment with Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants with Type 2 Diabetes - A Cross-over Study ⬇️

artículo científico publicado en 2018

The effects of pituitary and thyroid disorders on haemostasis: potential clinical implications

artículo científico publicado en 2015

The role of lectin-like oxidised low-density lipoprotein receptor-1 in vascular pathology

artículo científico

Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes ⬇️

artículo científico publicado en 2017

Vascular insulin-like growth factor-I resistance and diet-induced obesity

artículo científico publicado en 2009

Lista de obras de Ramzi Ajjan

A Novel and Practical Screening Tool for the Detection of Silent Myocardial Infarction in Patients With Type 2 Diabetes ⬇️

A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease

A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control

Antiplatelet Therapies in Diabetes

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

Cardiovascular magnetic resonance assessment of ventricular morphology to investigate the mechanisms of heart failure associated with type 2 diabetes

Cardiovascular magnetic resonance measures of aortic stiffness in asymptomatic patients with type 2 diabetes: association with glycaemic control and clinical outcomes ⬇️

Coagulation and atherothrombotic disease

Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity

Complement C3 and C-reactive protein levels in patients with stable coronary artery disease

Complement C3 is a novel plasma clot component with anti-fibrinolytic properties

Confusion over thiazolidinedione-induced heart failure: need for a better definition of heart failure

Coronary artery disease-associated genetic variants and biomarkers of inflammation ⬇️

Corrigendum: The Effect of a Simulated Commercial Flight Environment With Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants With Type 2 Diabetes - A Cross-Over Study.

Development of a supported self-management intervention for adults with type 2 diabetes and a learning disability. ⬇️

Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure ⬇️

Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology

Effects of MASP-1 of the Complement System on Activation of Coagulation Factors and Plasma Clot Formation ⬇️

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy ⬇️

Fibrin clot structure and platelet aggregation in patients with aspirin treatment failure

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial ⬇️

Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk ⬇️

Hypoglycaemia, thrombosis and vascular events in diabetes

Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study

Inhibition of complement C3 and fibrinogen interaction: a potential novel therapeutic target to reduce cardiovascular disease in diabetes

Insulin resistance and cardiovascular risk marker evaluation in morbid obesity 12 months after bariatric surgery compared to weight-matched controls

Managing with Learning Disability and Diabetes: OK-Diabetes - a case-finding study and feasibility randomised controlled trial ⬇️

Platelet count, platelet turnover and fibrin clot structure in patients with coronary artery disease

Prolonged Prothrombotic Effects of Antecedent Hypoglycemia in Individuals With Type 2 Diabetes ⬇️

Raising awareness of Graves' orbitopathy with early warning cards

Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke

The Effect of a Simulated Commercial Flight Environment with Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants with Type 2 Diabetes - A Cross-over Study ⬇️

The effects of pituitary and thyroid disorders on haemostasis: potential clinical implications

The role of lectin-like oxidised low-density lipoprotein receptor-1 in vascular pathology

Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes ⬇️

Vascular insulin-like growth factor-I resistance and diet-induced obesity